JUSTIN HARTFIELD

CBN, CBG, CBC · 4:54

What are CBN, CBG and CBC?

CBN, CBG and CBC are lesser-known cannabinoids: CBGA is a plant precursor, CBC shares that pathway, and CBN forms as THC ages.

CBN Cannabinoid, CBG and CBC: What the Trials Show Watch on YouTube Subscribe

Justin Hartfield connects minor-cannabinoid chemistry with Dr. Bob Melamede’s view of the body as an interacting system. Includes CBG research in mice and people, two CBN sleep trials, and the mouse-cell experiment behind CBC stem-cell claims.

The full answer

Three cannabinoids, one living system

What are CBN, CBG and CBC? They're three of the lesser-known cannabinoids: the acid form of CBG is the raw material the plant uses to make THC and CBD, CBC is made from that same raw material, and CBN is what THC turns into as it ages. I'm Justin Hartfield, and I've been selling cannabis for twenty-five years. CBN is sold for sleep and people take CBG for sleep, pain and anxiety, but only a handful of controlled trials in people stand behind those uses, and most of them are small. The biologist Dr. Bob Melamede, who I met in 2010, would bring another question to this discussion: how do these compounds interact with the living system they enter?

The biochemical orchestra

Bob described the endocannabinoid system as a conductor of life's biochemical orchestra because nerves, immune cells, and your metabolism are all separate interacting parts acting in coordination via energy to maintain themselves. In his thermodynamic framework, health depends on those interactions and feedback loops.

Where CBG and CBC come from

What is CBG? CBG is cannabigerol, and its acid form, CBGA, is the plant's starting material. Some people call it the stem cell cannabinoid or the mother cannabinoid because CBGA is the precursor to THC, CBD and CBC. The plant's enzymes reshape CBGA into THCA, CBDA or CBCA, the raw forms of THC, CBD and CBC. In US lab data, most flower had little CBG left, though nearly one sample in four had at least one percent. In tests on mouse brain tissue in 2009, CBG strongly switched on the alpha-2 receptor, which noradrenaline uses. It also blocked a serotonin receptor called 5-HT1A, and at high concentrations it blocked the CB1 lock too.

What is CBC cannabinoid? CBC is cannabichromene, the third cannabinoid the plant makes from CBGA, using its own enzyme. It's one of the most prominent cannabinoids in the plant. In one cell study, it switched on the CB2 lock but not CB1, and reviewers describe it as non-intoxicating. It also acts on several TRP channels, the family that includes TRPV1, the receptor that makes chili burn.

What CBG research shows

CBG acts at several biological targets, so it can’t be reduced to a single CB1 or CB2 switch as this would miss much of its pharmacology. In a 2013 experiment, CBG reduced inflammation in mice with chemically induced colitis and reduced some markers of oxidative stress in cells. In a 2024 trial, thirty-four healthy adults took CBG or a placebo in sessions run over video call. They reported less anxiety overall on CBG and did better on a verbal-memory test, without reported intoxication or measured impairment.

CBN and the chemistry of aging

CBN, cannabinol, has a different origin. THC can change into CBN through oxidation as cannabis ages. Light, air and storage conditions affect that chemistry. It is a concrete example of molecules changing over time, and it fits Bob's interest in oxidation and what he called biochemical friction. He would say time is a one-way street, and over time, things tend to degrade because of the laws of entropy. CBN has weaker activity at CB1 than THC, and older human experiments generally found much less intoxication from CBN alone.

Does CBN help you sleep?

The trials give a mixed answer. In a company-funded trial of about three hundred poor sleepers, CBN did not significantly improve the primary measure of overall sleep quality. Participants taking CBN alone did report fewer awakenings and less sleep disturbance. Adding CBD also did not improve the result. In a 2026 sleep-lab trial, twenty adults with insomnia received CBN or placebo on separate nights. Neither tested dose significantly reduced the primary measure: time spent awake after falling asleep. The higher dose improved some secondary measures, including time to fall asleep and subjective sleep quality, though.

What the CBC stem-cell experiment found

In 2013, researchers studied adult mouse neural stem and progenitor cells in a dish. CBC improved their viability during differentiation and changed markers associated with the cells' development. It also inhibited their differentiation into astroglia under those conditions.

To find out more about cannabinoids and how they work, watch the whole film on my site, linked below. Next: THCA vs THC, what's the difference?

Next answer What are terpenes in weed? Terpenes are the molecules you smell in cannabis. Only two controlled trials have added one terpene to THC: in one it helped, in the other it didn't.

What the studies show

Every claim in this answer, the study behind it, who was studied, and who paid for the research. “None listed” means the paper names no funder.

What the video saysSourceWho was studiedFunded by
The acid form of CBG is the raw material the plant uses to make THC and CBD, CBC is made from that same raw material, and CBN is what THC turns into as it ages Sirikantaramas 2004
Taura 2007
Elbouzidi 2026
Maioli 2022
enzyme cloning studies; reviews none listed for any of the four (one Maioli author also lists a chemistry company)
CBN is sold for sleep and people take CBG for sleep, pain and anxiety, but only a handful of controlled trials in people stand behind those uses, and most of them are small Maioli 2022
Lutz 2026
review; survey of 239 users Maioli: none listed; Lutz: none listed, and its co-authors include Ethan Russo (CReDO Science) and an author at a hemp company
Melamede described the endocannabinoid system as a conductor coordinating interacting biological processes. Melamede 2005 — Harm reduction: the cannabis paradox
Melamede 2020 — Why Does CBD Work?
Melamede — thermodynamic framework, EIHA 2015 and archived lectures
Authored review, sponsored essay and keynote; theoretical systems framework. The 2020 Orlando Magazine article is labeled Sponsored Post and was originally published by Blue Ribbon Hemp.
In US lab data, most flower had little CBG left, though nearly one sample in four had at least one percent Smith 2022 about 90,000 commercial samples, cross-sectional none listed; one author works for a strain-database company
In tests on mouse brain tissue in 2009, CBG strongly switched on the alpha-2 receptor, which noradrenaline uses; it also blocked the 5-HT1A serotonin receptor, and at high concentrations it blocked the CB1 lock too Cascio 2009 mouse brain membranes, cells and mouse tissue NIDA
CBG reduced experimentally induced colitis in mice and some oxidative-stress markers in cell experiments. Borrelli et al. 2013 — CBG in experimental colitis Mouse and cell experiments, 2013. Funding was not established in the materials checked.
In 2024, thirty-four healthy adults took twenty milligrams of CBG or a placebo a week apart, in sessions run over video call; on CBG they reported less anxiety overall and less stress at one point, did better on a word-memory test, with no sign of being high Cuttler 2024 34 adults, randomized double-blind placebo-controlled crossover field trial (Washington State University) none listed; co-author Ethan Russo lists CReDO Science
THC can form CBN through oxidation as cannabis ages; light, air and storage conditions influence that chemistry. Maioli 2022 review none listed
A 2021 review found that most of the human evidence shows CBN doesn't produce cannabis-like effects Corroon 2021 narrative review with a systematic search none listed
In a trial of about 300 poor sleepers, the primary overall sleep-quality outcome was not significant; awakenings and sleep disturbance improved on CBN alone, and CBD added no benefit. Bonn-Miller 2023 293 adults with self-rated poor sleep, randomized double-blind placebo-controlled a cannabis company (named in PubMed's grant list); eight of nine authors list that company and one a cannabis edibles company
In a 2026 laboratory crossover trial of 20 adults with insomnia, neither CBN dose significantly reduced the primary wake-after-sleep-onset measure; some secondary outcomes improved at the higher dose. Lavender 2026 20 adults, randomized double-blind placebo-controlled crossover, polysomnography none listed (academic: Woolcock Institute; Lambert Initiative, University of Sydney)
In one cell study, CBC switched on the CB2 lock but not CB1 Udoh 2019 cells none listed
Reviewers describe CBC as non-intoxicating; it acts on several TRP channels, the family that includes TRPV1; animal and cell studies point at inflammation and pain Elbouzidi 2026
Udoh 2019
review; cell study none listed for either
CBC improved viability during differentiation of adult mouse neural stem/progenitor cells and inhibited astroglial differentiation under the experimental conditions. Shinjyo and Di Marzo 2013 — CBC and neural stem/progenitor cells Adult mouse neural stem/progenitor cells in culture, 2013. Funding was not established in the materials checked.

Next answers

All 33 answers →

    Where this answer came from

    You’ve Been High Your Whole Life, the playable film

    Free, in English, Spanish and German. You run the experiments yourself.

    Get the next answer first

    Subscribe on YouTube, or get an email.